01Impact factor
Impact factor of Reviews on Recent Clinical Trials (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Reviews on Recent Clinical Trials published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 295 of 371 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Reviews on Recent Clinical Trials
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Reviews on Recent Clinical Trials is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Is your paper a fit for Reviews on Recent Clinical Trials?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
02Review time
Review time of Reviews on Recent Clinical Trials
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Reviews on Recent Clinical Trials published between Dec 2024 and Oct 2026 were accepted within 111 days of submission, and the middle half took between 90 and 150 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Pharmacology & Pharmacy, Reviews on Recent Clinical Trials ranks 81 of 157 journals by review time (1 = fastest). See the fastest-review journals in Pharmacology & Pharmacy →
Need a faster review? Reviews on Recent Clinical Trials takes a median of 111 days; the fastest journals in Pharmacology & Pharmacy take 3.
APC waivers and discounts for Reviews on Recent Clinical Trials
Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list.
03Funders
Who funds research published in Reviews on Recent Clinical Trials
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
04Indexing
Indexing of Reviews on Recent Clinical Trials
- ISSN
- 1574-8871
- eISSN
- 1876-1038
- Publisher
- Bentham Science Publishers all its journals →
- Country
- Netherlands
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Reviews on Recent Clinical Trials
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Reviews on Recent Clinical Trials accepts. You find it on the journal's website at Bentham Science Publishers, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Reviews on Recent Clinical Trials is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Reviews on Recent Clinical Trials
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Reviews on Recent Clinical Trials, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds07Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Reviews on Recent Clinical Trials when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 291 | European Journal of Hospital Pharmacy | 1.19 | SCIE | Subscription |
| 292 | Alcohol | 1.19 | SCIE | Subscription |
| 293 | Chinese Medicine | 1.19 | SCIE | Some open access |
| 294 | Therapies | 1.17 | SCIE | Subscription |
| 296 | FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology | 1.15 | SCIE | Fully open access |
| 297 | Pharmaceutical Chemistry Journal | 1.15 | SCIE | Subscription |
| 298 | Human Psychopharmacology Clinical and Experimental | 1.14 | SCIE | Subscription |
| 299 | American Journal of Pharmaceutical Education | 1.14 | SCIE | Some open access |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Reviews on Recent Clinical Trials right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,402 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
08Questions
Frequently asked questions
How long is the review time of Reviews on Recent Clinical Trials?
Based on 135 research articles Reviews on Recent Clinical Trials published from Dec 2024 to Oct 2026, the median time from submission to acceptance was 111 days, and half of them were accepted between 90 and 150 days. After acceptance, papers appeared online after a median of 159 days. Data updated October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Reviews on Recent Clinical Trials?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Reviews on Recent Clinical Trials is 1.16: papers it published in the two previous years were cited 1.16 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Reviews on Recent Clinical Trials?
The h-index of Reviews on Recent Clinical Trials is 43 (October 2026): 43 of its papers have each been cited at least 43 times. Its i10-index is 286.
What is the quartile of Reviews on Recent Clinical Trials?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Reviews on Recent Clinical Trials is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Reviews on Recent Clinical Trials indexed in Scopus?
Yes. Reviews on Recent Clinical Trials appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Reviews on Recent Clinical Trials an SCIE journal?
Reviews on Recent Clinical Trials is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Reviews on Recent Clinical Trials in Journal Citation Reports (JCR)?
Yes. Reviews on Recent Clinical Trials is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Reviews on Recent Clinical Trials offer an APC waiver?
Reviews on Recent Clinical Trials follows the policy of Bentham Science: 50% discount for corresponding authors in countries on Bentham's low-income list. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Reviews on Recent Clinical Trials?
3% of 148 recent research articles in Reviews on Recent Clinical Trials name a funder; the funders named most often are Hamadan University of Medical Science, Hamadan, Iran, vice chancellor for research and technology, Hamadan University of Medical Sciences, Hamadan, Iran, Natural Science Foundation of Beijing, China.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- RSC Advances
- Japanese Journal Of Applied Physics
- Nucleic Acids Research
- Journal of Agricultural and Food Chemistry
- Industrial and Engineering Chemistry Research
- Materials Science and Engineering: A
- Nature Communications
- Materials Letters
- Physical Review C
- Physical Chemistry Chemical Physics
- Journal of Colloid and Interface Science
- Transplantation
- Biochemistry
- Science of the Total Environment
Browse all journals: indexing, impact factor and reviewer comments →